One Year Later: How Insurers Are Covering Zurzuvae, the First Postpartum Depression Pill
It’s been a year since Zurzuvae™, the first oral postpartum depression drug...
Focus Area: Insurance Coverage
Addressing the Need to “Carve In” Mental Health Care at the Kennedy Forum’s Alignment for Progress Event
On September 24th and 25th, the Policy Center for Maternal Mental Health...
Long Awaited Federal Mental Health Parity Rules Released
Today, the Federal Government released new regulations to enforce the Federal Mental...
Mental Health Parity and Payment, Considerations for Maternal Mental Health
This year, the Policy Center collaborated with the Federal Department of Labor...
Large Employers Aim to Drive Change in Maternal Health
This month PBGH members released the first Comprehensive Maternity Care (CMC) Common...
New Federal Maternal Mental Health Bill Introduced Requiring Mental Health Coverage with No Cost Share for the Privately Insured
A new Federal bill was introduced last week by Democratic Senators to...
Zurzuvae, the New Postpartum Depression Drug Now Available in the U.S. – This is How Insurers Have Responded
Zurzuvae™, the new first-of-its-kind 14-day postpartum depression pill, recently available in the...
An Open Letter to CMS regarding Ob Reimbursement for MMH Services
Our work shaping and reporting on national mental health policy is made...
The Cost of ZURZUVAE™ – After Insurance Coverage
On November 7, 2023, Sage Therapeutics announced the wholesale cost of ZURZUVAE™,...
1-9 of 13 Results
Load More Articles